Concepedia

Yoko Oei

YO

Statistics

Publications

14

Citations

4.8K

H-Index

14

Active since

1996

Affiliations

Novartis (United States)(Current)

Novartis Institutes for BioMedical Research

BioNTech (Germany)

Genesys (United States)

Novartis (Switzerland)

Yoko Oei is an author at Novartis (United States) specializing in oncology, medicine, and molecular oncology.

Publications per year

1996–2022

14

Publications

14

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Stephanie M. Pyonteck, Leila Akkari, Alberto J. Schuhmacher et al. · Nature Medicine · 2013 · 2.5K citations · Full text

, , +12

IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines

Siri Tähtinen, Ann-Jay Tong, Patricia Himmels et al. · Nature Immunology · 2022 · 519 citations · Full text

, , +15

Human Endothelial Cell Life Extension by Telomerase Expression

Jiwei Yang, Edwin Chang, Athena M. Cherry et al. · Journal of Biological Chemistry · 1999 · 494 citations · Full text

, , +16

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8<sup>+</sup>T cells

Debbie Strachan, Brian Ruffell, Yoko Oei et al. · OncoImmunology · 2013 · 377 citations · Full text

, , +17

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis

Darlene E. Jenkins, Yoko Oei, Yvette S. Hornig et al. · Clinical & Experimental Metastasis · 2003 · 283 citations

, , +16

1–5 of 14